News

Findings of a new phase 3 trial support the use of secnizadole in patients with trichomoniasis.

Racial disparities exist among patients receiving dialysis.

Dr. Louis Kovacs discusses the risk of playing youth, college, and professional sports during the ongoing pandemic.

A single nucleotide polymorphism is associated with severe and proliferative retinopathy risk reduction by 42% and 63%, respectively.

From immunity building to plasma research, a look at some lesser efficient practices adopted or proposed during the pandemic.

The findings can lead to an alternative pain option for patients with sickle cell disease.

An expert discusses how a registry of gastrointestinal symptoms is leading research during COVID-19.

According to new findings, low Glx response is associated with increase in clinical improvements in at-need patients.

The study addresses safety concerns related to the risk of keratinocyte carcinoma for patients with atopic dermatitis.

The approval is based on findings from a phase 2 clinical trial.

Less than 1% of nearly 500,000 hospitalized patients required kidney replacement therapy.

Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.

The goal is to begin delivering safe and effective COVID-19 vaccines to the Amerian people.

REGENXBIO also announced the scheduling of a phase 2 trial testing RGX-314 for wet AMD.

Guideline adoption could lead to more use of thrombolytic therapy.

The risk of depression or clinically relevant depressive symptoms did not significantly differ between a group taking Vitamin D and a group taking a placebo.

Additional monitoring is needed among patients receiving opioid therapy.

Patients with IPF and multiple comorbidities experienced similar effects from nintedanib to those with few or no comorbidities.

Tiotropium plus olodaterol is more effective for patients with COPD compared with LABA plus inhaled corticosteroids.

MagVenture TMS Therapy can be used as adjunctive therapy to other OCD treatments.

In a comparison with manual human grading, investigators find machine learning model produced no statically significant differences in Dice coefficients.

In a cross-sectional study among CAD patients, investigators found that 30.3% of heart team treatment recommendations diverged from original consultation.

David Ho, MD, likens and contrasts the pandemic to 3 other viral outbreaks and their respective responses.

A team of researchers have added 3 new modifiable risk factors to a list of 9 known factors that increase the risk of developing dementia.

An expert in Alzheimer disease describes some of the struggles dementia patients might be going through during the COVID-19 pandemic.

New data shows an adherence to troponin testing could complement optimized care.

Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.

In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.